Abstract

US labelling for Rituxan [rituximab] has been updated to include a warning regarding hepatitis B reactivation and fulminant hepatitis,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call